US Stock and Financial News

Pfizer Is Reportedly In ‘Advanced Talks’ To Buy Global Blood Therapeutics For $5 Billion

Rumors that Pfizer is in “advanced talks” to acquire Global Blood Therapeutics for about $5 billion sent GBT stock flying Friday.

Related Articles

Back to top button